Approaching pre-Diabetes

Leigh Perreault*, Kristine Færch

*Corresponding author af dette arbejde
54 Citationer (Scopus)

Abstract

As the global epidemic of type 2 diabetes continues to rise, the time has come to revisit our approach to pre-diabetes. Recently, much ado has been made about screening, diagnosis, pathophysiology and clinical interventions in pre-diabetes, and all for good reason as the key to reversing the diabetes epidemic likely lies therein. The somewhat controversial term "pre-diabetes" represents collective dysglycemic states intermediate between normal glucose regulation (NGR) and diabetes. Not all people with pre-diabetes will develop diabetes, but the majority will. In fact, up to 70% of those with pre-diabetes may acquire the disease over their lifetime. Furthermore, even when overt diabetes is delayed or prevented, both micro- and macrovascular disease appears more prevalent in those with pre-diabetes compared to their normoglycemic peers. Hence, there is growing consensus that NGR should be the goal for people with pre-diabetes. Nevertheless, there is much to consider in that pursuit. Herein, we provide an update on the global burden of pre-diabetes, its underlying pathophysiology and discuss clinical considerations in these individuals at high risk of developing diabetes.

OriginalsprogEngelsk
TidsskriftJournal of Diabetes and its Complications
Vol/bind28
Udgave nummer2
Sider (fra-til)226-233
Antal sider8
ISSN1056-8727
DOI
StatusUdgivet - mar. 2014
Udgivet eksterntJa

Fingeraftryk

Dyk ned i forskningsemnerne om 'Approaching pre-Diabetes'. Sammen danner de et unikt fingeraftryk.

Citationsformater